Acyclovir
- Product NDC
- 71205-472
- 11-digit product format
- 712050472
- Labeler code
- 71205
- Product ID
- 71205-472_17c98e9b-bcc4-4909-b6ce-0e11d786081a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acyclovir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Proficient Rx LP
- Application
- ANDA210401
- Marketing category
- ANDA
- Marketing start
- 2018-05-04
- Substance
- ACYCLOVIR
- Active strength
- 400 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| X4HES1O11F | ACYCLOVIR | 59277-89-3 | ACYCLOVIR |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71205-472-15 | 71205047215 | 15 TABLET in 1 BOTTLE (71205-472-15) | 15 tablet | 2020-08-21 | No | No | Historical |
| 71205-472-30 | 71205047230 | 30 TABLET in 1 BOTTLE (71205-472-30) | 30 tablet | 2020-08-21 | No | No | Historical |
| 71205-472-60 | 71205047260 | 60 TABLET in 1 BOTTLE (71205-472-60) | 60 tablet | 2020-08-21 | No | No | Historical |
| 71205-472-90 | 71205047290 | 90 TABLET in 1 BOTTLE (71205-472-90) | 90 tablet | 2020-08-21 | No | No | Historical |